American Chemical Society
- Assets
- $870.6k
- Revenue
- $396.0k
- Investments
- $0.0
- Employees
- 0
- Location
- Arlington, MA
- Founding
- 03/1955
- Data as of
- 12/2023
- EIN
- 39-6065798
Organization Overview
American Chemical Society, operating under the name Division of Biochemical Technology, is located in Arlington, MA. The organization was established in 1955. According to its NTEE Classification (U03) the organization is classified as: Professional Societies & Associations, under the broad grouping of Science & Technology and related organizations. This organization is a subordinate organization within an affiliated group for tax-exemption purposes. Division of Biochemical Technology is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Division of Biochemical Technology generated $396.0k in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 2.2% each year. All expenses for the organization totaled $464.8k during the year ending 12/2023. While expenses have increased by 5.8% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO PROMOTE INFORMATION SHARING ON BIOCHEMICAL TECHNOLOGY
Describe the Organization's Program Activity:
Part 3 - Line 4a
BI-ANNUAL SCIENTIFIC SYMPOSIA IN BIOTECHNOLOGY HOSTED BY THE RECOVERY OF BIOLOGICAL PRODUCTS CONFERENCE SERIES AND ACS DIVISION OF BIOCHEMICAL TECHNOLOGY. THE BIENNIAL CONFERENCES ARE AN INTERNATIONAL CROSSROADS WHERE ACADEMIA MEETS INDUSTRY IN THE PURSUIT OF CUTTING EDGE AND TRANS-DISCIPLINARY SCIENCE AND TECHNOLOGY. THE MEETINGS ARE CHARACTERIZED BY ACTIVE PARTICIPATION, DYNAMIC EXCHANGE OF IDEAS AND VIEWS ON NASCENT AND EMERGING TECHNOLOGIES AND DISCUSSION OF THE FUTURE IMPACT OF PERIPHERAL SCIENCES ON THE INDUSTRIAL APPLICATION OF RECOVERY TECHNOLOGIES. ORAL AND POSTER SESSIONS, WORKSHOPS AND PANEL DISCUSSIONS ARE ORGANIZED TO FOCUS ON A SYSTEMATIC AND INTEGRATED APPROACH TO PROCESS DESIGN AND TO STRENGTHEN THE BRIDGE BETWEEN ACADEMIC DISCOVERY AND INDUSTRIAL IMPLEMENTATION, RESOLUTION OF INDUSTRIAL ISSUES AND DECISION-MAKING IN PRODUCT DEVELOPMENT. LEADING REGULATORY PRESENCE ASSURES A DIALOG ESSENTIAL TO PRODUCT SAFETY AND THE TIMELY INTRODUCTION OF NOVEL, GROUND BREAKING TREATMENT OF UNMET MEDICAL NEEDS. TO MAINTAIN THE SCIENTIFIC STANDARDS AND QUALITY OF THE CONFERENCE, PARTICIPATION IS LIMITED AND BY INVITATION. LEADERS IN THE FIELD OF BIOLOGICAL PRODUCT RECOVERY AND RELATED SCIENCES ARE ABLE TO EXCHANGE INNOVATIVE IDEAS IN AN ATMOSPHERE FREE FROM COMMERCIAL, CORPORATE OR PUBLISHING PRESSURES, IN LOCATIONS WHICH ARE CONDUCIVE TO NETWORKING, BUILDING FRUITFUL PROFESSIONAL RELATIONSHIPS, MAKING NEW FRIENDS AND RENEWING OLD FRIENDSHIPS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Varnika Roy Past-Chair | OfficerTrustee | 5.8 | $0 |
Michelle O'malley Chair | OfficerTrustee | 5.8 | $0 |
Venkatesh Natarajan Treasurer | OfficerTrustee | 2.9 | $0 |
Mark Blenner Long Range Program Chair | OfficerTrustee | 2.3 | $0 |
Raquel Orozco Alternate Councillor & Diversi | Trustee | 0.8 | $0 |
Brian Pfleger Awards Chair | Trustee | 0.6 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $336,490 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $336,490 |
| Total Program Service Revenue | $59,121 |
| Investment income | $414 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $396,025 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $50,579 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $3,562 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $62,820 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $26,454 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $321,368 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $464,783 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $456,918 |
| Savings and temporary cash investments | $413,712 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $870,630 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Net assets without donor restrictions | $870,630 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $870,630 |